These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10087608)

  • 21. Cell microencapsulation.
    Lim GJ; Zare S; Van Dyke M; Atala A
    Adv Exp Med Biol; 2010; 670():126-36. PubMed ID: 20384223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immuno-isolation in cancer gene therapy.
    Cirone P; Potter M; Hirte H; Chang P
    Curr Gene Ther; 2006 Apr; 6(2):181-91. PubMed ID: 16611041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel approach to tumor suppression with microencapsulated recombinant cells.
    Cirone P; Bourgeois JM; Austin RC; Chang PL
    Hum Gene Ther; 2002 Jul; 13(10):1157-66. PubMed ID: 12133269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of new small barium alginate microcapsules.
    Cappai A; Petruzzo P; Ruiu G; Congiu T; Dessy E; De Seta W; Santa Cruz G; Brotzu G
    Int J Artif Organs; 1995 Feb; 18(2):96-102. PubMed ID: 7558404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 12. Biodegradable polymer nanoparticles as protein delivery systems: Original research articles: Design of biodegradable particles for protein delivery (2002), Chitosan nanoparticles as delivery systems for doxorubicin (2001); design of microencapsulated chitosan microspheres for colonic drug delivery (1998).
    Csaba N; Alonso MJ
    J Control Release; 2014 Sep; 190():53-4. PubMed ID: 25356482
    [No Abstract]   [Full Text] [Related]  

  • 26. Immuno-isolation in oncology--a mini-review.
    Cirone P; Saller RM; Chang PL
    Curr Pharm Biotechnol; 2001 Sep; 2(3):269-77. PubMed ID: 11530880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth retardation--an unexpected outcome from growth hormone gene therapy in normal mice with microencapsulated myoblasts.
    Al-Hendy A; Hortelano G; Tannenbaum GS; Chang PL
    Hum Gene Ther; 1996 Jan; 7(1):61-70. PubMed ID: 8825869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Creation of a prevascularized site for cell transplantation in rats.
    Stiegler P; Matzi V; Pierer E; Hauser O; Schaffellner S; Renner H; Greilberger J; Aigner R; Maier A; Lackner C; Iberer F; Smolle-Jüttner FM; Tscheliessnigg K; Stadlbauer V
    Xenotransplantation; 2010; 17(5):379-90. PubMed ID: 20955294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth and survival of renal failure rats that received oral microencapsulated genetically engineered E. coli DH5 cells for urea removal.
    Prakash S; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 1998 Jan; 26(1):35-51. PubMed ID: 9507755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selected aspects of the microencapsulation of mammalian cells in HEMA-MMA.
    Sefton MV; Hwang JR; Babensee JE
    Ann N Y Acad Sci; 1997 Dec; 831():260-70. PubMed ID: 9616718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The development of encapsulated cell technologies as therapies for neurological and sensory diseases.
    Zanin MP; Pettingill LN; Harvey AR; Emerich DF; Thanos CG; Shepherd RK
    J Control Release; 2012 May; 160(1):3-13. PubMed ID: 22285549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular therapies for kidney failure.
    Hammerman MR
    Expert Opin Biol Ther; 2006 Feb; 6(2):87-97. PubMed ID: 16436035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Making microencapsulation work: conformal coating, immobilization gels and in vivo performance.
    Sefton MV; May MH; Lahooti S; Babensee JE
    J Control Release; 2000 Mar; 65(1-2):173-86. PubMed ID: 10699279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a novel bile acid-based delivery platform for microencapsulated pancreatic β-cells.
    Mooranian A; Negrulj R; Arfuso F; Al-Salami H
    Artif Cells Nanomed Biotechnol; 2016; 44(1):194-200. PubMed ID: 25014218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The advance and limitation of microencapsulated grafts transplantation].
    Lin H; Cai X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):678-83. PubMed ID: 16856415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of human factor IX by microencapsulated recombinant fibroblasts.
    Liu HW; Ofosu FA; Chang PL
    Hum Gene Ther; 1993 Jun; 4(3):291-301. PubMed ID: 8338876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function.
    Zhang H; Zhu SJ; Wang W; Wei YJ; Hu SS
    Gene Ther; 2008 Jan; 15(1):40-8. PubMed ID: 17943144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiangiogenic cancer therapy with microencapsulated cells.
    Cirone P; Bourgeois JM; Chang PL
    Hum Gene Ther; 2003 Jul; 14(11):1065-77. PubMed ID: 12885346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small agarose microcapsules with cell-enclosing hollow core for cell therapy: transplantation of Ifosfamide-activating cells to the mice with preestablished subcutaneous tumor.
    Sakai S; Hashimoto I; Tanaka S; Salmons B; Kawakami K
    Cell Transplant; 2009; 18(8):933-9. PubMed ID: 19500478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of field effects to generate calcium alginate microspheres and its application in cell transplantation.
    Hsu BR; Chen HC; Fu SH; Huang YY; Huang HS
    J Formos Med Assoc; 1994 Mar; 93(3):240-5. PubMed ID: 7920065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.